Active Clinical Trials
Clinical trials are at the heart of our work to bring innovative medicines to people with a particular disease or condition. Learn more about the active studies conducted by Novartis including opportunities to get involved.
- Sort by Sort ascending
- Study title
- Condition
- Phase
- Location
| Study title | Condition | Phase | Location | |
|---|---|---|---|---|
A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers |
Ovarian Cancer, Lung Cancer | Phase1 | Israel | NCT06376253 |
24 Weeks Double-blind Randomized Placebo-controlled Trial to Evaluate Efficacy, PK, Safety of LOU064 in Adolescents (12 - <18) With CSU and Inadequate Response to H1-antihistamine Followed by Optional 3 Years Open-label Extension and an Optional 3 Years Safety Long-term Treatment-free Follow-up |
Chronic Spontaneous Urticaria | Phase3 | Argentina Canada China Germany Hong Kong Italy Japan Malaysia Netherlands Poland Singapore South Africa Spain Thailand Turkey United Kingdom United States View All |
NCT05677451 |
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis |
Lupus Nephritis | Phase3 | Argentina Brazil Canada Chile China Colombia Czechia Estonia France Germany Guatemala Hong Kong Hungary India Italy Korea, Republic of Lithuania Malaysia Mexico Romania Singapore Spain Taiwan Thailand United Kingdom United States Vietnam View All |
NCT05126277 |
A Multi-center Study to Evaluate the Safety, Tolerability and Efficacy of TIN816 in Patients at Risk for Acute Kidney Injury Following Cardiac Surgery. |
Acute Kidney Injury Following Cardiac Surgery | Phase2 | Argentina Belgium Brazil Canada Czechia Estonia France Germany Hungary Singapore Spain Taiwan United States View All |
NCT05524051 |